ADDvise Group AB A (ADDV-A) - Net Assets
Based on the latest financial reports, ADDvise Group AB A (ADDV-A) has net assets worth Skr1.06 Billion SEK (≈ $114.51 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr2.92 Billion ≈ $314.08 Million USD) and total liabilities (Skr1.85 Billion ≈ $199.56 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ADDV-A tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr1.06 Billion |
| % of Total Assets | 36.46% |
| Annual Growth Rate | 37.84% |
| 5-Year Change | 330.33% |
| 10-Year Change | 2211.05% |
| Growth Volatility | 229.27 |
ADDvise Group AB A - Net Assets Trend (2007–2025)
This chart illustrates how ADDvise Group AB A's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of ADDvise Group AB A to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for ADDvise Group AB A (2007–2025)
The table below shows the annual net assets of ADDvise Group AB A from 2007 to 2025. For live valuation and market cap data, see ADDV-A company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.06 Billion ≈ $114.51 Million |
+27.44% |
| 2024-12-31 | Skr835.00 Million ≈ $89.86 Million |
+36.17% |
| 2023-12-31 | Skr613.20 Million ≈ $65.99 Million |
+24.41% |
| 2022-12-31 | Skr492.87 Million ≈ $53.04 Million |
+99.32% |
| 2021-12-31 | Skr247.28 Million ≈ $26.61 Million |
+171.58% |
| 2020-12-31 | Skr91.05 Million ≈ $9.80 Million |
+8.21% |
| 2019-12-31 | Skr84.14 Million ≈ $9.06 Million |
+63.67% |
| 2018-12-31 | Skr51.41 Million ≈ $5.53 Million |
+4.90% |
| 2017-12-31 | Skr49.01 Million ≈ $5.27 Million |
+6.44% |
| 2016-12-31 | Skr46.04 Million ≈ $4.96 Million |
+982.88% |
| 2015-12-31 | Skr4.25 Million ≈ $457.58K |
-71.42% |
| 2014-12-31 | Skr14.88 Million ≈ $1.60 Million |
+34.36% |
| 2013-12-31 | Skr11.07 Million ≈ $1.19 Million |
+14.79% |
| 2012-12-31 | Skr9.65 Million ≈ $1.04 Million |
+4.37% |
| 2011-12-31 | Skr9.24 Million ≈ $994.69K |
+114.70% |
| 2010-12-31 | Skr4.30 Million ≈ $463.29K |
+85.24% |
| 2008-12-31 | Skr2.32 Million ≈ $250.10K |
-29.49% |
| 2007-12-31 | Skr3.30 Million ≈ $354.70K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ADDvise Group AB A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr60.61 Million | 5.70% |
| Other Components | Skr1.00 Billion | 94.30% |
| Total Equity | Skr1.06 Billion | 100.00% |
ADDvise Group AB A Competitors by Market Cap
The table below lists competitors of ADDvise Group AB A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lasa Supergenerics Limited
NSE:LASA
|
$4.23 Million |
|
ABM International Limited
NSE:ABMINTLLTD
|
$4.23 Million |
|
Gold Basin Resources Corp
V:GXX
|
$4.24 Million |
|
Beston Global Food Company Ltd
AU:BFC
|
$4.24 Million |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
$4.22 Million |
|
Algorhythm Holdings, Inc.
NASDAQ:RIME
|
$4.22 Million |
|
Indo Komoditi Korpora Tbk PT
JK:INCF
|
$4.21 Million |
|
Zelira Therapeutics Ltd
AU:ZLD
|
$4.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ADDvise Group AB A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 835,000,000 to 1,064,100,000, a change of 229,100,000 (27.4%).
- Net income of 3,100,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 37,900,000.
- Other factors increased equity by 263,900,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr3.10 Million | +0.29% |
| Other Comprehensive Income | Skr-37.90 Million | -3.56% |
| Other Changes | Skr263.90 Million | +24.8% |
| Total Change | Skr- | 27.44% |
Book Value vs Market Value Analysis
This analysis compares ADDvise Group AB A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.83x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | Skr1.93 | Skr1.72 | x |
| 2008-12-31 | Skr1.36 | Skr1.72 | x |
| 2010-12-31 | Skr1.18 | Skr1.72 | x |
| 2011-12-31 | Skr1.64 | Skr1.72 | x |
| 2012-12-31 | Skr0.90 | Skr1.72 | x |
| 2013-12-31 | Skr0.71 | Skr1.72 | x |
| 2014-12-31 | Skr1.27 | Skr1.72 | x |
| 2015-12-31 | Skr0.18 | Skr1.72 | x |
| 2016-12-31 | Skr1.04 | Skr1.72 | x |
| 2017-12-31 | Skr0.76 | Skr1.72 | x |
| 2018-12-31 | Skr1.19 | Skr1.72 | x |
| 2019-12-31 | Skr0.89 | Skr1.72 | x |
| 2020-12-31 | Skr0.80 | Skr1.72 | x |
| 2021-12-31 | Skr1.73 | Skr1.72 | x |
| 2022-12-31 | Skr2.78 | Skr1.72 | x |
| 2023-12-31 | Skr3.30 | Skr1.72 | x |
| 2024-12-31 | Skr4.24 | Skr1.72 | x |
| 2025-12-31 | Skr2.08 | Skr1.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ADDvise Group AB A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.29%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.19%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 2.74x
- Recent ROE (0.29%) is above the historical average (-24.47%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 33.40% | 3.30% | 2.83x | 3.57x | Skr771.40K |
| 2008 | -41.78% | -2.83% | 2.66x | 5.56x | Skr-1.20 Million |
| 2010 | -110.82% | -21.41% | 1.04x | 5.00x | Skr-5.20 Million |
| 2011 | -2.98% | -0.54% | 2.16x | 2.53x | Skr-1.20 Million |
| 2012 | -37.27% | -3.58% | 1.48x | 7.03x | Skr-4.56 Million |
| 2013 | -41.23% | -3.80% | 1.37x | 7.89x | Skr-5.67 Million |
| 2014 | -32.00% | -3.45% | 0.83x | 11.19x | Skr-6.25 Million |
| 2015 | -261.01% | -7.57% | 1.14x | 30.33x | Skr-11.52 Million |
| 2016 | 0.81% | 0.19% | 0.87x | 4.89x | Skr-4.22 Million |
| 2017 | -11.90% | -2.42% | 0.86x | 5.69x | Skr-10.70 Million |
| 2018 | -2.09% | -0.40% | 0.92x | 5.68x | Skr-6.19 Million |
| 2019 | 4.83% | 1.16% | 0.97x | 4.29x | Skr-4.34 Million |
| 2020 | 16.09% | 4.08% | 1.04x | 3.80x | Skr5.54 Million |
| 2021 | 1.13% | 0.60% | 0.44x | 4.32x | Skr-21.92 Million |
| 2022 | 16.45% | 8.52% | 0.48x | 3.99x | Skr31.81 Million |
| 2023 | 16.88% | 7.54% | 0.42x | 5.36x | Skr42.18 Million |
| 2024 | 10.78% | 5.39% | 0.48x | 4.13x | Skr6.50 Million |
| 2025 | 0.29% | 0.19% | 0.55x | 2.74x | Skr-103.31 Million |
Industry Comparison
This section compares ADDvise Group AB A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $746,134,778
- Average return on equity (ROE) among peers: -100.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ADDvise Group AB A (ADDV-A) | Skr1.06 Billion | 33.40% | 1.74x | $4.23 Million |
| ADDvise Group B (ADDV-B) | $247.28 Million | 1.13% | 3.32x | $108.58 Million |
| AddLife AB (publ) (ALIF-B) | $4.97 Billion | 9.66% | 1.63x | $1.96 Billion |
| Biotage AB (BIOT) | $902.36 Million | 0.00% | 0.06x | $1.23 Billion |
| Bio-Works Technologies AB (BIOWKS) | $37.46 Million | -118.94% | 0.21x | $38.42 Million |
| Bonesupport Holding AB (BONEX) | $265.70 Million | -32.19% | 0.29x | $1.49 Billion |
| Dynavox Group (DYVOX) | $210.60 Million | 23.08% | 5.28x | $717.33 Million |
| iZafe Group AB Series B (IZAFE-B) | $11.69 Million | -142.71% | 2.05x | $18.00 Million |
| Ortivus AB ser. A (ORTI-A) | $66.95 Million | -33.27% | 0.25x | $393.65K |
| Ortivus AB ser. B (ORTI-B) | $2.18 Million | -613.98% | 11.70x | $17.17 Million |
About ADDvise Group AB A
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more